Courbevoie, France

Claire Amadei


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Claire Amadei: Innovator in Cytomegalovirus Diagnostics

Introduction

Claire Amadei is a notable inventor based in Courbevoie, France. She has made significant contributions to the field of medical diagnostics, particularly in the detection of infections caused by human cytomegaloviruses. With a total of 2 patents to her name, her work has the potential to impact healthcare practices significantly.

Latest Patents

Amadei's latest patents focus on the development of anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses. The first patent describes a process that involves contacting cells, which may carry the infection, with a monoclonal antibody that reacts with a specific polypeptide of molecular weight 68,000. This polypeptide is induced by human cytomegalovirus and possesses protein-kinase activity. The detection of the reaction is preferably carried out through immunofluorescence, providing a reliable method for diagnosing infections.

Career Highlights

Throughout her career, Claire Amadei has worked with prestigious institutions, including the Institut Pasteur. Her innovative research has contributed to advancements in the field of virology and diagnostics.

Collaborations

Amadei has collaborated with notable colleagues such as Florian Horaud and Susan Michelson, enhancing her research through teamwork and shared expertise.

Conclusion

Claire Amadei's contributions to the field of cytomegalovirus diagnostics exemplify her dedication to innovation and healthcare improvement. Her patents represent a significant step forward in the diagnosis of viral infections, showcasing her role as a leading inventor in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…